Robert T. Peters

Person

Needham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Optimized factor IX gene
- Patent number 12,275,970
- Issue date Apr 15, 2025
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII chimeric and hybrid polypeptides, and methods of use th...
- Patent number 12,186,375
- Issue date Jan 7, 2025
- Bioverativ Therapeutics Inc.
- Jennifer A. Dumont
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acid molecules and uses thereof
- Patent number 12,168,776
- Issue date Dec 17, 2024
- Bioverativ Therapeutics Inc.
- Alexey Seregin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Optimized factor VIII gene
- Patent number 11,787,851
- Issue date Oct 17, 2023
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,401,322
- Issue date Aug 2, 2022
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric factor VIII polypeptides and uses thereof
- Patent number 11,370,827
- Issue date Jun 28, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use...
- Patent number 11,266,720
- Issue date Mar 8, 2022
- Bioverativ Therapeutics Inc.
- Jennifer A. Dumont
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Procoagulant compounds
- Patent number 11,261,437
- Issue date Mar 1, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong Hong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of using FIX polypeptides
- Patent number 11,225,650
- Issue date Jan 18, 2022
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using FIX polypeptides
- Patent number 11,193,116
- Issue date Dec 7, 2021
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII chimeric proteins and uses thereof
- Patent number 11,192,936
- Issue date Dec 7, 2021
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,168,125
- Issue date Nov 9, 2021
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric clotting factors
- Patent number 11,168,316
- Issue date Nov 9, 2021
- Bioverativ Therapeutics, Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII complex with XTEN and von Willebrand Factor protein, an...
- Patent number 11,091,534
- Issue date Aug 17, 2021
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,084,866
- Issue date Aug 10, 2021
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Optimized factor IX gene
- Patent number 11,008,561
- Issue date May 18, 2021
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric clotting factors
- Patent number 10,968,442
- Issue date Apr 6, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processable single chain molecules and polypeptides made using same
- Patent number 10,927,362
- Issue date Feb 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor IX polypeptides and methods of use thereof
- Patent number 10,898,554
- Issue date Jan 26, 2021
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII chimeric and hybrid polypeptides, and methods of use th...
- Patent number 10,881,742
- Issue date Jan 5, 2021
- Bioverativ Therapeutics Inc.
- Jennifer A. Dumont
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor IX fusion proteins and methods of making and using same
- Patent number 10,745,680
- Issue date Aug 18, 2020
- Bioverativ Therapeutics Inc.
- Zhiqian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor IX polypeptides and methods of use thereof
- Patent number 10,568,943
- Issue date Feb 25, 2020
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor IX polypeptides and methods of use thereof
- Patent number 10,561,714
- Issue date Feb 18, 2020
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII-XTEN fusions and uses thereof
- Patent number 10,548,953
- Issue date Feb 4, 2020
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor IX polypeptides and methods of use thereof
- Patent number 10,548,954
- Issue date Feb 4, 2020
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 10,513,551
- Issue date Dec 24, 2019
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII compositions and methods of making and using same
- Patent number 10,421,798
- Issue date Sep 24, 2019
- Bioverativ Therapeutics Inc.
- Volker Schellenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized factor VIII gene
- Patent number 10,370,431
- Issue date Aug 6, 2019
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-GPIIB/IIIA antibodies or uses thereof
- Patent number 10,364,288
- Issue date Jul 30, 2019
- Biogen MA Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Procoagulant compounds
- Patent number 10,287,564
- Issue date May 14, 2019
- Bioverativ Therapeutics Inc.
- Vu Phong Hong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
NUCLEIC ACID MOLECULES AND USES THEREOF
- Publication number 20250171805
- Publication date May 29, 2025
- Bioverativ Therapeutics Inc.
- Alexey SEREGIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED FACTOR IX GENE
- Publication number 20250154489
- Publication date May 15, 2025
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITOR-RESISTANT MGMT MODIFICATIONS AND MODIFICATION OF MGMT-ENC...
- Publication number 20250135039
- Publication date May 1, 2025
- Ensoma, Inc.
- Robert Thomas Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED FACTOR VIII GENE
- Publication number 20240141019
- Publication date May 2, 2024
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20230322900
- Publication date Oct 12, 2023
- Bioverativ Therapeutics Inc.
- Volker Schellenberger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES BINDING TO COAGULATION FACTOR IX AND COAGULAT...
- Publication number 20230192896
- Publication date Jun 22, 2023
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
- Publication number 20230023927
- Publication date Jan 26, 2023
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20230019286
- Publication date Jan 19, 2023
- Bioverativ Therapeutics Inc.
- Volker SCHELLENBERGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF
- Publication number 20230011438
- Publication date Jan 12, 2023
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
- Publication number 20220275057
- Publication date Sep 1, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE...
- Publication number 20220265780
- Publication date Aug 25, 2022
- Bioverativ Therapeutics Inc.
- Jennifer A. DUMONT
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
PROCOAGULANT COMPOUNDS
- Publication number 20220243189
- Publication date Aug 4, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong HONG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF
- Publication number 20220213200
- Publication date Jul 7, 2022
- Biogen MA Inc.
- Joe Salas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20220135959
- Publication date May 5, 2022
- Bioverativ Therapeutics Inc.
- Joe SALAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES
- Publication number 20220089745
- Publication date Mar 24, 2022
- Biogen MA Inc.
- Bradley Pearse
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF USING FIX POLYPEPTIDES
- Publication number 20220064622
- Publication date Mar 3, 2022
- Bioverativ Therapeutics Inc.
- Glenn PIERCE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AN...
- Publication number 20220056108
- Publication date Feb 24, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
- Publication number 20220010000
- Publication date Jan 13, 2022
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20210355473
- Publication date Nov 18, 2021
- Bioverativ Therapeutics Inc.
- Joe SALAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA
- Publication number 20210348150
- Publication date Nov 11, 2021
- Bioverativ Therapeutics Inc.
- Daniel S. Rivera
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME
- Publication number 20210292729
- Publication date Sep 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20210238259
- Publication date Aug 5, 2021
- Bioverativ Therapeutics Inc.
- Arjan VAN DER FLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE TH...
- Publication number 20210220476
- Publication date Jul 22, 2021
- Bioverativ Therapeutics Inc.
- Jennifer A. DUMONT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACID MOLECULES AND USES THEREOF
- Publication number 20210163986
- Publication date Jun 3, 2021
- Bioverativ Therapeutics Inc.
- Alexey SEREGIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED FACTOR IX GENE
- Publication number 20210115425
- Publication date Apr 22, 2021
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII
- Publication number 20210038744
- Publication date Feb 11, 2021
- BIOVERATIV THERAPEUTICS INC.
- Andrea ANNONI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20210032616
- Publication date Feb 4, 2021
- Bioverativ Therapeutics Inc.
- Zhiqian LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210023185
- Publication date Jan 28, 2021
- Bioverativ Therapeutics Inc.
- Glenn PIERCE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210008178
- Publication date Jan 14, 2021
- Bioverativ Therapeutics Inc.
- Glenn PIERCE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES
- Publication number 20200354459
- Publication date Nov 12, 2020
- Biogen MA Inc.
- Bradley Pearse
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Robert T. Peters

Person

Patents Grantslast 30 patents

Optimized factor IX gene

Factor VIII chimeric and hybrid polypeptides, and methods of use th...

Nucleic acid molecules and uses thereof

Optimized factor VIII gene

Immunoglobulin chimeric monomer-dimer hybrids

Chimeric factor VIII polypeptides and uses thereof

Factor VIII-FC chimeric and hybrid polypeptides, and methods of use...

Procoagulant compounds

Methods of using FIX polypeptides

Methods of using FIX polypeptides

Factor VIII chimeric proteins and uses thereof

Immunoglobulin chimeric monomer-dimer hybrids

Chimeric clotting factors

Factor VIII complex with XTEN and von Willebrand Factor protein, an...

Immunoglobulin chimeric monomer-dimer hybrids

Optimized factor IX gene

Chimeric clotting factors

Processable single chain molecules and polypeptides made using same

Factor IX polypeptides and methods of use thereof

Factor VIII chimeric and hybrid polypeptides, and methods of use th...

Factor IX fusion proteins and methods of making and using same

Factor IX polypeptides and methods of use thereof

Factor IX polypeptides and methods of use thereof

Factor VIII-XTEN fusions and uses thereof

Factor IX polypeptides and methods of use thereof

Immunoglobulin chimeric monomer-dimer hybrids

Factor VIII compositions and methods of making and using same

Optimized factor VIII gene

Anti-GPIIB/IIIA antibodies or uses thereof

Procoagulant compounds

Patents Applicationslast 30 patents

NUCLEIC ACID MOLECULES AND USES THEREOF

OPTIMIZED FACTOR IX GENE

INHIBITOR-RESISTANT MGMT MODIFICATIONS AND MODIFICATION OF MGMT-ENC...

OPTIMIZED FACTOR VIII GENE

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

BISPECIFIC ANTIBODIES BINDING TO COAGULATION FACTOR IX AND COAGULAT...

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE...

PROCOAGULANT COMPOUNDS

ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF

CHIMERIC CLOTTING FACTORS

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

METHODS OF USING FIX POLYPEPTIDES

FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AN...

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

CHIMERIC CLOTTING FACTORS

CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA

PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE TH...

NUCLEIC ACID MOLECULES AND USES THEREOF

OPTIMIZED FACTOR IX GENE

USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF

FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES